CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 28 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $764,000 | -99.1% | 906,000 | -99.1% | 0.02% | -99.2% |
| Q3 2018 | $89,573,000 | -13.3% | 95,856,000 | 0.0% | 2.72% | -14.5% |
| Q2 2018 | $103,358,000 | +1.4% | 95,856,000 | +9.7% | 3.18% | +31.8% |
| Q1 2018 | $101,883,000 | -11.2% | 87,346,000 | +2.9% | 2.42% | -28.7% |
| Q4 2017 | $114,699,000 | +6.9% | 84,846,000 | +22.4% | 3.39% | -11.0% |
| Q3 2017 | $107,321,000 | -9.8% | 69,346,000 | -1.1% | 3.81% | -24.1% |
| Q2 2017 | $118,981,000 | +136.4% | 70,125,000 | +79.8% | 5.01% | +168.0% |
| Q1 2017 | $50,328,000 | +786.7% | 39,000,000 | +609.1% | 1.87% | +746.6% |
| Q4 2016 | $5,676,000 | -80.0% | 5,500,000 | -67.6% | 0.22% | -88.7% |
| Q3 2015 | $28,391,000 | – | 16,994,000 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 70,125,000 | $118,981,000 | 5.01% |
| PFM Health Sciences, LP | 46,790,999 | $79,428,000 | 2.14% |
| Partner Investment Management, L.P. | 790,001 | $1,341,000 | 1.80% |
| Myriad Asset Management Ltd. | 10,000,000 | $16,984,000 | 1.18% |
| CSS LLC/IL | 10,950,000 | $18,558,000 | 0.90% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $15,403,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 2,784,000 | $4,715,000 | 0.42% |
| ZAZOVE ASSOCIATES LLC | 4,030,000 | $6,833,000 | 0.36% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,826,000 | $13,277,000 | 0.25% |
| LORD, ABBETT & CO. LLC | 18,243,000 | $30,967,000 | 0.09% |